CCTG BR34: A Randomized Phase 2 Trial of Durvalumab and Tremelimumab With or Without Platinum-Based Chemotherapy in Patients With Metastatic NSCLC

202144 citationsJournal Article

Authors

Good health and well-being

Published in: Journal of Thoracic Oncology

Volume 17, Issue 3, pp. 434-445

Field-Weighted Citation Impact: 2.86